Hospitals May Be Required to Test for Fentanyl in Urine Drug Screening

June 30, 2023

Assembly Bill 5489, introduced in the New Jersey General Assembly on May 18, 2023, would require any hospital conducting a urine drug screening to assist in diagnosing a patient’s condition to also include a test for the presence of fentanyl. Currently, urine drug screenings typically include tests for cocaine, certain opioids, and phencyclidine, but not fentanyl. Mandatory testing for the presence of fentanyl could help prevent overdose deaths by ensuring that patients who have ingested fentanyl, either intentionally or unintentionally, receive proper treatment for a fentanyl overdose.

Click Here to read the entire June 2023 Healthcare Law Update now!

For more information, contact:
John D. Fanburg, Chair | 973.403.3107 | jfanburg@bracheichler.com
Edward Hilzenrath | 973.403.3114 | ehilzenrath@bracheichler.com
Vanessa Coleman | 973.364.5208 | vcoleman@bracheichler.com

---

Attorney Advertising: This publication is designed to provide Brach Eichler LLC clients and contacts with information they can use to more effectively manage their businesses. The contents of this publication are for informational purposes only. Neither this publication nor the lawyers who authored it are rendering legal or other professional advice or opinions on specific facts or matters. Brach Eichler LLC assumes no liability in connection with the use of this publication.